GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs: Company Secretary Resigns Effective June 19, 2026

MANAGEMENT ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 19 Jun 2026, 04:07 PM IST  ·  BSE ID: dc76f2c3-23df-4d0d-81c6-2eae6ec7c469
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's chief governance officer and legal secretary has left their role, effective today.
🤖 AI Summary
  • Ms. Palak Jain resigned as Company Secretary, Compliance Officer, and key managerial personnel.
  • The resignation from Welcure Drugs & Pharmaceuticals Ltd. is effective June 19, 2026.
  • The Board of Directors has accepted the resignation and thanked Ms. Jain.
  • This event is disclosed under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
🏢 How This Affects the Company
⚙️
Operational Impact
The company will need to appoint a new Company Secretary and Compliance Officer to ensure regulatory adherence.
⚠️
Risk Impact
There is a temporary heightened risk of non-compliance with SEBI regulations until a replacement is appointed and fully integrated.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders.
👤
Who Is Affected
All shareholders are affected by changes in key managerial personnel that impact corporate governance.
🔍
Management Signal
The Board's prompt acceptance and appreciation signal a commitment to continued operational stability.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Announcement of new Company Secretary and Compliance Officer appointment.
Confirmation of replacement's qualifications and start date.
Subsequent board meeting minutes confirming new appointments.
LOW RISK This is a routine management change; the company will appoint a successor.
💡 Investor Takeaway
Welcure Drugs & Pharmaceuticals Ltd. reported the resignation of its Company Secretary and Compliance Officer, effective June 19, 2026. The Board has acknowledged the departure and thanked the individual for their service.
❓ Frequently Asked Questions
Who resigned from Welcure Drugs & Pharmaceuticals Ltd.?
Ms. Palak Jain resigned as Company Secretary, Compliance Officer, and key managerial personnel.
When was the resignation of Ms. Palak Jain effective?
The resignation was effective from the close of business hours of June 19, 2026.
What is the company's response to the resignation?
The Board of Directors has noted the resignation and expressed appreciation for Ms. Jain's contributions.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.